ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

JSPRW Jasper Therapeutics Inc

0.1475
0.00 (0.00%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5,910
Bid Price 0.1202
Ask Price 0.1399
News -
Day High 0.1485

Low
0.0351

52 Week Range

High
0.3818

Day Low 0.1202
Company Name Stock Ticker Symbol Market Type
Jasper Therapeutics Inc JSPRW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.1475 19:58:28
Open Price Low Price High Price Close Price Prev Close
0.1202 0.1202 0.1485 0.1475 0.1475
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
25 5,910 $ 0.1343845 $ 794 - 0.0351 - 0.3818
Last Trade Time Type Quantity Stock Price Currency
16:00:00 100 $ 0.1385 USD

Jasper Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
307M 15.06M - 0 -64.47M -4.28 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Jasper Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No JSPRW Message Board. Create One! See More Posts on JSPRW Message Board See More Message Board Posts

Historical JSPRW Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.15960.16750.1010.132342620,315-0.0121-7.58%
1 Month0.22430.230.1010.166734627,760-0.0768-34.24%
3 Months0.11890.27140.1010.17795830,1610.028624.05%
6 Months0.1080.38180.03510.137316527,6290.039536.57%
1 Year0.170.38180.03510.126309120,032-0.0225-13.24%
3 Years1.732.240.0160.528369429,681-1.58-91.47%
5 Years1.732.240.0160.528369429,681-1.58-91.47%

Jasper Therapeutics Description

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Your Recent History

Delayed Upgrade Clock